Academic Week 4 Flashcards
What are the precipitating factors for a DKA or HHS?
Inadequate insulin therapy, infection, new onset diabetes, metabolic stressors (surgery/emotions), glucocorticoids, antipsychotics and excess diuretics.
How should pituitary micro-adenomas be treated?
These are slow growing and only require observation
How should pituitary macro-adenomas be treated?
These are known for their locally invasive properties but distant metastases are very rare. They may require surgical intervention.
What is the difference between Cushing’s disease and Cushing’s syndrome?
Cushing’s disease originates in the pituitary with excess ACTH secretion whereas Cushing’s syndrome is the symptoms of cortisol excess.
How does hypopituitism present?
GH deficiency, gonadotrophin deficiency, ACTH deficiency, TSH deficiency or vasopressin deficiency.
This should be tested with dynamic hormone measurements such as TSH stimulation tests, GnRH stimulation or glucagon test.
How should pituitary hyper function be assessed such as Cushing’s disease?
Dexamethasone suppression test for Cushing’s
Oral glucose testing with GH measurement is also an option
MRI is the preferred choice of imaging
How does hyperprolactinemia present?
This presents with amenorrhoea and galactorrhea. They will have suppressed LH and FSH with elevated prolactin levels.
What are the causes of hyperprolactinemia?
Hypothyroidism, PCOS, pituitary stalk compression or pituitary masses.
How does Cushing’s disease/syndrome present?
Type 2 diabetes, weight gain, easy bruising, hypertension and excess cortisol of blood tests.
Dexamethasone suppression test is used to determine whether it is Cushing’s syndrome or disease.
What are the characteristics of acromegaly?
Macroglossia, enlarged facial shape, tall stature and cardiac abnormalities.
How are prolactinomas treated medically?
Bromocriptine and cabergoline which are dopamine agonists as this inhibits prolactin
How is acromegaly treated medically?
Somatostatin analogs (octreotide) and pegvisomant
How is Cushing’s disease treated medically?
Ketoconazole, metyrapine and mitotane
How does multiple endocrine neoplasia type 1 present? (MEN1)
Parathyroid tumours (95%), enteropancreatic tumours and anterior pituitary tumours. These patients almost always present with hypoparathyroidism and possibly incidentilomas
Describe follicular adenomas of the thyroid?
On histopathology follicular adenomas show compression and fibrotic changes in the thyroid around the tumour capsule. This is a well circumscribed tumour and is non-invasive.
Describe the features of thyroid follicular carcinomas?
These are less circumscribed than follicular adenomas, which show vascular invasion. These typically metastasise to the bones, lungs and lymph nodes. The tumour resembles thyroid follicles and distant metastases occur in 20%.
Describe the features of thyroid papillary carcinomas?
Histologically they have a papillary architecture with characteristic nuclear changes. Size determines the treatment and mortality.
Describe the features of thyroid medullary carcinomas?
These are endocrine carcinomas derived from C cells (which produce calcitonin). It is caused by activating mutations in the RET oncogene. 20% are linked with MEN2A or 2B. These can be stained for calcitonin to prove it is medullary.
Describe the feature of thyroid anaplastic carcinomas?
These are the result of de-differentiation and aggressive transformation of a follicular or papillary carcinomas. It is p53 mutation associated and they are very aggressive.
All anaplastic tumours are staged at T4 regardless of size.
How do thyroid neoplasms present?
They usually present as solitary nodules. Most solitary thyroid nodules are non-neoplastic, inflammatory or hyperplasia related.
Younger men are more likely to have malignancy thyroid nodules.
What is the treatment for malignant thyroid nodules?
Surgery followed by radio iodine ablation of the remaining tissue.
How are malignant thyroid nodules diagnosed and scored?
Fine needle aspiration is used to diagnose solitary and malignant nodules and cytology is scored using the Thy scoring system.
If TSH is normal or high then FNA is strongly recommended whereas if it is low then a scan is needed.
Describe the Thy scoring system of thyroid malignancies
- Non-diagnostic or unsatisfactory (1c is cyst)
- All benign lesions
3a - Neoplasm is possible but unclear
3f - Neoplasm possible and likely follicular - Suspicious of any malignancy
- Malignant
Any Thy score over 3 requires surgery
Describe some long acting insulins
Insulin deter (Levemir), glargine (Lantus) and Degludec (Tresiba)
Describe some rapid acting insulins
Novorapid (insulin aspart) and Humalog (lispo)
Describe the biochemical properties of insulin
Insulin is made of an alpha and a beta polypeptide chain which are joined by two disulphide links. There is a C peptide chain that has no physiological significance and is excreted in urine which allows measurement of endogenous insulin production. Exogenous insulin analogues have small amino acid changes which affects the duration of the injected insulin action.
What is the first line treatment for type 2 diabetes?
Lifestyle changes
Describe the mechanism of action, side effects and contraindications for metformin
Metformin is a biguanide which is first line pharmacotherapy for T2DM. It inhibits gluconeogenesis and decreases hepatic glucose output.
It also increases insulin mediated glucose utilisation and reduces lipolysis and free fatty acids.
Side effects on nausea, vomiting, bloating and diarrhoea .
Contraindications include renal impairment, liver disease, alcohol excess or lactic acidosis.
Describe some sulphonylureas
These directly stimulate insulin secretion from beta cells by binding to ATP-sensitive potassium channels.
The types now used include Gliclazide and glimepiride. They are shorter acting and are renally excreted.
These can be used as a first line treatment or in combination with metformin. They are well tolerated and can be used for patients with CKD. Side effects include hypoglycaemia and weight gain. They are used in MODY.
Describe GLP 1 receptor agonists
GLP-1 is produced by L cells in the small intestine and is secreted in response to nutrient intake. Incretin effect is the augmentation of insulin secretion after oral intake of glucose as opposed to intravenous administration of glucose. The incretin effect in patients with T2DM is dramatically reduced and in some cases has stopped. The GLP agonist activate the GLP receptor which causes increased insulin secretion, suppressed glucagon secretion, slower gastric emptying, increases satiety (which leads to weight loss) and beta cell proliferation. Examples include liraglutide, exenatide and dulaglutide.
These are often used for patients with a BMI over 35. Side effects include acute pancreatitis, GI symptoms, headaches, gallbladder disease and can cause DKA if insulin is also being used. They should be avoided in pregnancy and severe hepatic impairment. Liraglutide is contraindicated in gastroparesis, IBD and severe CCF.